Leramistat
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Modern Biosciences Ltd
Overview
Leramistat is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Leramistat clinical trials
Explore related
Medical disclaimer. This page summarizes research about Leramistat for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.